Cosmetics manufacturer Intercos is working on at least one US acquisition to expand its skin and hair care business https://t.co/wNzGtsNscd ...

Company Overview - Nu Skin Enterprises (NUS) shares increased by 6.2% to close at $12.84, with trading volume significantly higher than usual, contrasting with a 0.3% loss over the past four weeks [1] - The company operates in the cosmetics industry and utilizes a direct-selling model for its skin care and nutritional products [3][6] Strategic Execution - The company's growth is attributed to operational efficiency, innovation focus, and international expansion, with the Rhyz Manufacturing segment showing consistent growth [2] - The upcoming AI-powered Prysm iO device is expected to enhance customer engagement and subscriptions, while lessons from fast-growing markets will guide international expansion [2] Financial Performance - Nu Skin is projected to report quarterly earnings of $0.30 per share, reflecting a year-over-year increase of 76.5%, while revenues are expected to be $374.2 million, a decrease of 13% from the previous year [3] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a potential lack of momentum in earnings estimate revisions [5] Market Position - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [6] - In comparison, European Wax Center, another company in the same industry, has also maintained a Zacks Rank of 3 and is expected to report an EPS of $0.14, a 16.7% increase year-over-year [6][7]

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Company Overview - Coty is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenues [2]. Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution, retailer inventory buildup, and challenges from previous fiscal year innovations. The company noted a slowdown in cosmetics sales due to value-seeking behavior and U.S.-specific factors [3]. - Following the announcement of these results, Coty's stock price fell by $1.05 per share, a decline of over 21%, from $4.86 to $3.81 between August 20 and August 21, 2025 [3].

Opening Bid Unfiltered is available on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. In the world of cosmetics, few companies are as well-known as Revlon. Founded in 1932, Revlon continues to be a significant force in the ever-changing world of cosmetics. However, the company has seen its ups and downs in recent decades. The cosmetics industry has evolved into one heavily driven by celebrities like Kylie Jenner and popular names on TikTok's social platform. At the same time, Revlon’s ...

Core Viewpoint - The acquisition of Rhode by e.l.f. Beauty is expected to significantly enhance the company's market position and growth potential in the cosmetics industry, particularly through increased distribution and product expansion opportunities [3][5][12]. Company Overview - e.l.f. Beauty has successfully gained substantial market share in the mass cosmetics category, resonating well with younger consumers and expanding its retail presence [2]. - The company has seen its stock price more than double since earlier purchases, indicating strong market confidence following the acquisition of Rhode [3]. Acquisition Details - The acquisition of Rhode, valued at $1 billion, closed in August and is seen as a transformative move for e.l.f. Beauty, providing access to a high-end skincare brand with impressive sales of $212 million in under three years [5][6]. - Rhode's brand, backed by celebrity Hailey Bieber, has only a limited product range, presenting significant opportunities for e.l.f. to expand its offerings [7]. Distribution Strategy - Distribution gains are identified as a critical growth driver for consumer products, and e.l.f. is poised to leverage its existing strengths in influencer marketing to promote the Rhode brand [8][11]. - Rhode has already begun entering Sephora stores, with plans to expand into U.K. locations and potentially other retailers like Ulta Beauty and Target, which could further enhance its market presence [9][10]. Financial Outlook - e.l.f. Beauty's stock is currently trading at a forward price-to-earnings (P/E) ratio of 42, with a price/earnings-to-growth (PEG) ratio of 0.5, suggesting that the stock may be undervalued given its growth prospects [12].

South Korea has long been a mecca for skincare enthusiasts, and part of Rejuran’s success is due to a broader interest in Korea-born beauty products and rituals. But some American doctors remain skeptical.🔗 https://t.co/34kPaFvyxF https://t.co/Bkdwr6zeCh ...

Core Points - Natura Cosméticos has entered into a binding agreement to sell its Avon International business to an acquisition vehicle affiliated with Regent, excluding the Russian market and Latin American operations [1] - The sale will provide Natura with a nominal consideration of 1 pound, with potential contingent payments up to 60 million pounds based on future results and liquidity events [2] - The sale of Avon International, along with the sale of Avon business in Central America, is part of Natura's strategy to streamline operations and focus on its core business in Latin America [3] Additional Details - Natura has also agreed to sell the Avon business in Guatemala, Nicaragua, Panama, Honduras, El Salvador, and the Dominican Republic to Grupo PDC, while continuing to supply finished goods and licensing the Avon brand in that region [4] - The company has been exploring options for Avon's international business intermittently [4]

Core Viewpoint - Brazilian cosmetics maker Natura has agreed to sell its Avon International unit to Regent, marking the end of uncertainty regarding this business segment and resulting in a more than 13% increase in Natura's shares traded in Sao Paulo [1]. Group 1: Strategic Moves - Natura is executing divestitures to simplify its structure, integrate business units, and focus on the Latin American market after facing profitability challenges in recent years [2]. - The company has previously divested brands such as Aesop and The Body Shop, and recently announced a deal to sell Avon's businesses in Central America to Grupo PDC [2]. Group 2: Details of the Sale - The sale of Avon International includes operations in Europe, Africa, and Asia, but excludes Avon's Russian business, which is still "held for sale," and its Latin American operations, which are central to Natura's strategy [3]. - The U.S. business of Avon, which was never owned by Natura, is also not included in this transaction [3]. Group 3: Financial Implications - Natura will receive a nominal consideration of 1.00 pound ($1.36) at closing, with contingent payments based on future results and certain liquidity events capped at 60 million pounds [4]. - Analysts at Santander noted that this move should alleviate concerns regarding the need for additional cash injections to sustain Avon's operations, as Avon International has been a cash-burning unit [4].

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in relation to investments and financial instruments [1]. Group 1 - The website provides general news, personal analysis, and third-party content intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to perform their own research and consider their financial situation before making decisions [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to understand how these instruments work and the associated risks before investing [1].

Group 1: Stock Performance - e.l.f. Beauty closed at $146.11, with a +1.98% change from the previous day, outperforming the S&P 500's daily loss of 0.1% [1] - Over the past month, e.l.f. Beauty shares gained 19.57%, while the Consumer Staples sector lost 2.31% and the S&P 500 gained 2.57% [1] Group 2: Earnings Expectations - Analysts expect e.l.f. Beauty to report earnings of $0.61 per share, reflecting a year-over-year decline of 20.78% [2] - The consensus estimate for revenue is $368.95 million, which represents a 22.54% increase from the prior-year quarter [2] Group 3: Full Year Estimates - For the full year, analysts expect earnings of $3.54 per share and revenue of $1.65 billion, indicating changes of +4.42% and +25.97% respectively from last year [3] Group 4: Analyst Estimate Revisions - Recent modifications to analyst estimates for e.l.f. Beauty indicate changing near-term business trends, with positive revisions suggesting analyst optimism [4] Group 5: Zacks Rank and Performance - The Zacks Rank system, which assesses estimate changes, currently ranks e.l.f. Beauty at 3 (Hold), with a 1.3% upward shift in the consensus EPS estimate over the past month [6] Group 6: Valuation Metrics - e.l.f. Beauty has a Forward P/E ratio of 40.48, significantly higher than its industry's Forward P/E of 15.67 [7] - The company has a PEG ratio of 2.63, compared to the Cosmetics industry's average PEG ratio of 1.42 [7] Group 7: Industry Context - The Cosmetics industry, part of the Consumer Staples sector, ranks in the bottom 17% of all industries according to the Zacks Industry Rank [8]